Amgen Raises 2026 Revenue Outlook to $38.9 Billion to $39.7 Billion

Amgen raised its full-year 2026 revenue and non-GAAP earnings-per-share outlook on Tuesday, Nov. 3, projecting revenue of $38.9 billion to $39.7 billion and earnings per share of $22.90 to $23.70.

Both guidance ranges are higher than the company’s previous outlook. The earnings-per-share figure uses Amgen’s non-GAAP methodology.

Amgen’s third-quarter revenue increased 8% from a year earlier to $10.4 billion. Amgen expects a meaningful sequential increase in fourth-quarter operating expenses.